Author:
Shimada Nagashige,Sugawa Satoshi,Murakami Satoshi,Shinoda Masahiro,Ota Shinichiro,Morikawa Miwa,Takei Hiroaki,Serizawa Yusuke,Takahashi Hidenori,Toyama-Kousaka Mio,Matsuse Hiroto,Shinkai Masaharu
Funder
Abbott Laboratories
Abbott Japan Kabushiki Kaisha
Reference28 articles.
1. Characteristics of SARS- CoV-2 and COVID-19;Hu;Nat Rev Microbiol,2021
2. WHO. Coronavirus (COVID-19) Dashboard. World Health Organization, https://covid19.who.int/table; [accessed 6 Sep 2023].
3. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020
4. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months;Levin;N Engl J Med,2021
5. Bansal D, Atia H, Badr MA, Nour M, Abdulmajeed J, Hasan A, et al. Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar Vaccines 2023;11:496. Doi: 10.3390/vaccines11030496.